Nifty
Sensex
:
:
23587.50
78041.59
-364.20 (-1.52%)
-1176.46 (-1.49%)

Pharmaceuticals & Drugs - API

Rating :
N/A

BSE: 524558 | NSE: NEULANDLAB

13891.15
20-Dec-2024
  • Open
  • High
  • Low
  • Previous Close
  •  14310.00
  •  14605.00
  •  13800.00
  •  14428.25
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  56752
  •  8024.75
  •  18100.00
  •  5021.10

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 17,834.83
  • 63.77
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 17,841.98
  • 0.10%
  • 12.79

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 32.64%
  • 5.06%
  • 26.50%
  • FII
  • DII
  • Others
  • 26.46%
  • 4.84%
  • 4.50%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 12.76
  • 15.36
  • 17.90

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 21.38
  • 35.34
  • 26.53

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 34.11
  • 79.26
  • 67.53

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 31.71
  • 28.17
  • 25.96

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 3.67
  • 3.86
  • 5.03

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 15.62
  • 15.73
  • 17.33

Earnings Forecasts:

Description
2024
2025
2026
2027
Adj EPS
233.89
250.46
385.6
490.56
P/E Ratio
68.7
64.16
41.67
32.76
Revenue
1516
1641
2163
2686
EBITDA
463
467
711
896
Net Income
300
308
497
633
ROA
17.6
P/Bk Ratio
16.07
12.96
9.92
7.63
ROE
26.36
21.39
26.96
26.33
FCFF
112.02
287.93
358.15
435.04
FCFF Yield
0.59
1.5
1.87
2.27

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Net Sales
310.84
417.75
-25.59%
439.60
362.99
21.11%
385.01
407.07
-5.42%
392.83
269.25
45.90%
Expenses
248.62
280.26
-11.29%
316.24
266.07
18.86%
278.09
287.21
-3.18%
271.56
215.17
26.21%
EBITDA
62.23
137.49
-54.74%
123.36
96.92
27.28%
106.92
119.86
-10.80%
121.27
54.08
124.24%
EBIDTM
20.02%
32.91%
28.06%
26.70%
27.77%
29.44%
30.87%
20.09%
Other Income
4.33
3.05
41.97%
4.81
2.04
135.78%
5.36
8.06
-33.50%
2.10
0.93
125.81%
Interest
1.06
4.43
-76.07%
2.67
2.21
20.81%
3.61
4.29
-15.85%
3.74
2.75
36.00%
Depreciation
16.07
14.51
10.75%
16.28
13.59
19.79%
16.46
13.47
22.20%
15.14
13.34
13.49%
PBT
49.42
121.59
-59.36%
129.84
83.16
56.13%
92.20
110.16
-16.30%
104.48
38.94
168.31%
Tax
16.58
32.35
-48.75%
31.97
21.28
50.23%
24.64
25.62
-3.83%
23.09
8.39
175.21%
PAT
32.84
89.25
-63.20%
97.87
61.88
58.16%
67.56
84.54
-20.09%
81.39
30.55
166.42%
PATM
10.57%
21.36%
22.26%
17.05%
17.55%
20.77%
20.72%
11.35%
EPS
25.46
69.18
-63.20%
75.86
47.96
58.17%
52.37
65.53
-20.08%
63.09
23.68
166.43%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Net Sales
1,528.28
1,558.58
1,191.20
951.08
936.91
762.71
666.83
527.41
578.89
509.97
469.15
Net Sales Growth
4.89%
30.84%
25.25%
1.51%
22.84%
14.38%
26.43%
-8.89%
13.51%
8.70%
 
Cost Of Goods Sold
574.10
577.29
478.23
422.14
438.42
380.20
366.24
238.37
262.90
253.46
243.99
Gross Profit
954.18
981.30
712.97
528.94
498.50
382.51
300.59
289.04
315.99
256.52
225.16
GP Margin
62.44%
62.96%
59.85%
55.61%
53.21%
50.15%
45.08%
54.80%
54.59%
50.30%
47.99%
Total Expenditure
1,114.51
1,095.99
919.36
808.46
790.09
660.82
608.46
476.98
472.55
429.52
402.53
Power & Fuel Cost
-
48.72
48.62
42.21
39.21
32.75
26.81
25.95
25.78
22.24
22.53
% Of Sales
-
3.13%
4.08%
4.44%
4.19%
4.29%
4.02%
4.92%
4.45%
4.36%
4.80%
Employee Cost
-
257.06
201.79
182.47
149.74
123.56
110.46
102.99
92.74
65.38
51.81
% Of Sales
-
16.49%
16.94%
19.19%
15.98%
16.20%
16.56%
19.53%
16.02%
12.82%
11.04%
Manufacturing Exp.
-
107.79
86.94
89.16
77.10
64.84
50.10
55.54
44.90
39.31
43.56
% Of Sales
-
6.92%
7.30%
9.37%
8.23%
8.50%
7.51%
10.53%
7.76%
7.71%
9.28%
General & Admin Exp.
-
60.91
51.22
35.80
38.93
27.75
27.49
33.32
28.30
29.72
23.59
% Of Sales
-
3.91%
4.30%
3.76%
4.16%
3.64%
4.12%
6.32%
4.89%
5.83%
5.03%
Selling & Distn. Exp.
-
33.94
29.58
27.40
34.63
18.30
18.28
14.04
11.16
17.52
14.54
% Of Sales
-
2.18%
2.48%
2.88%
3.70%
2.40%
2.74%
2.66%
1.93%
3.44%
3.10%
Miscellaneous Exp.
-
10.29
22.99
9.28
12.08
13.42
9.08
6.77
6.78
1.89
14.54
% Of Sales
-
0.66%
1.93%
0.98%
1.29%
1.76%
1.36%
1.28%
1.17%
0.37%
0.54%
EBITDA
413.78
462.59
271.84
142.62
146.82
101.89
58.37
50.43
106.34
80.45
66.62
EBITDA Margin
27.07%
29.68%
22.82%
15.00%
15.67%
13.36%
8.75%
9.56%
18.37%
15.78%
14.20%
Other Income
16.60
12.54
9.75
2.08
16.10
3.89
3.49
4.53
1.17
1.78
0.78
Interest
11.08
14.00
13.07
13.50
17.90
21.57
15.66
18.93
21.09
24.48
27.36
Depreciation
63.95
59.70
52.78
49.04
39.68
31.28
25.86
22.10
19.23
15.74
15.32
PBT
375.94
401.44
215.75
82.16
105.33
52.92
20.34
13.93
67.19
42.00
24.72
Tax
96.28
101.36
52.23
18.34
24.70
36.71
3.90
1.87
20.32
14.92
8.79
Tax Rate
25.61%
25.25%
24.21%
22.32%
23.45%
69.37%
19.17%
13.42%
30.24%
35.52%
35.56%
PAT
279.66
300.08
163.52
63.82
80.63
16.21
16.44
12.06
46.86
27.33
15.94
PAT before Minority Interest
279.66
300.08
163.52
63.82
80.63
16.21
16.44
12.06
46.86
27.08
15.93
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.25
0.01
PAT Margin
18.30%
19.25%
13.73%
6.71%
8.61%
2.13%
2.47%
2.29%
8.09%
5.36%
3.40%
PAT Growth
5.05%
83.51%
156.22%
-20.85%
397.41%
-1.40%
36.32%
-74.26%
71.46%
71.46%
 
EPS
218.48
234.44
127.75
49.86
62.99
12.66
12.84
9.42
36.61
21.35
12.45

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Shareholder's Funds
1,282.70
994.10
840.50
786.46
709.96
699.31
558.04
545.62
186.63
161.38
Share Capital
12.90
12.90
12.90
12.90
12.90
12.90
8.95
8.95
8.95
8.95
Total Reserves
1,269.80
981.20
827.60
773.56
697.06
686.41
238.24
225.81
177.68
152.42
Non-Current Liabilities
122.17
146.71
179.83
169.82
163.39
104.06
146.43
54.37
69.42
54.76
Secured Loans
44.92
74.25
104.25
88.13
77.37
60.72
103.49
29.81
33.40
21.22
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
12.00
12.00
Long Term Provisions
7.61
10.29
11.91
9.44
12.49
11.91
9.87
9.28
6.85
6.38
Current Liabilities
427.68
438.96
363.16
368.51
357.63
326.98
366.93
285.60
268.00
295.14
Trade Payables
191.96
171.01
117.38
152.13
115.56
119.68
124.29
85.92
83.86
111.81
Other Current Liabilities
234.01
244.87
152.35
158.75
71.63
57.45
41.83
47.18
55.02
31.28
Short Term Borrowings
0.00
11.16
92.21
56.98
168.17
149.06
199.20
151.08
123.63
145.80
Short Term Provisions
1.72
11.93
1.21
0.64
2.27
0.80
1.59
1.41
5.50
6.25
Total Liabilities
1,832.55
1,579.77
1,383.49
1,324.79
1,230.98
1,130.35
1,071.40
885.59
524.05
511.53
Net Block
804.64
738.19
747.70
696.94
622.76
511.69
445.01
435.74
138.77
123.07
Gross Block
1,072.98
950.36
913.27
826.48
714.33
575.44
483.45
454.74
291.78
263.65
Accumulated Depreciation
268.34
212.17
165.57
129.54
91.57
63.75
38.44
19.00
153.00
140.58
Non Current Assets
911.48
818.87
802.70
775.20
715.79
676.88
624.20
510.54
209.87
195.76
Capital Work in Progress
45.89
40.57
20.46
17.25
23.75
104.47
126.09
19.60
40.48
41.47
Non Current Investment
1.28
0.52
0.50
19.35
30.17
30.21
30.21
30.20
7.39
7.39
Long Term Loans & Adv.
40.47
20.24
14.38
41.67
35.81
30.51
22.66
24.79
22.73
23.83
Other Non Current Assets
0.17
0.00
0.00
0.00
3.30
0.00
0.22
0.22
0.50
0.00
Current Assets
921.08
760.89
580.79
549.59
515.19
453.47
447.19
375.04
314.19
315.77
Current Investments
0.00
0.00
3.38
6.46
7.50
7.50
7.50
7.50
0.00
0.00
Inventories
350.42
279.23
265.21
247.61
219.55
192.65
175.09
135.11
126.66
113.40
Sundry Debtors
373.53
361.77
234.33
217.73
189.89
164.02
193.92
181.11
119.11
128.85
Cash & Bank
116.80
59.10
20.36
19.40
46.98
37.84
17.26
12.49
9.71
6.98
Other Current Assets
80.33
13.70
11.52
8.84
51.27
51.46
53.43
38.83
58.70
66.53
Short Term Loans & Adv.
62.03
47.09
46.00
49.55
33.80
31.77
37.15
25.30
46.68
45.23
Net Current Assets
493.40
321.94
217.64
181.08
157.55
126.49
80.27
89.45
46.18
20.63
Total Assets
1,832.56
1,579.76
1,383.49
1,324.79
1,230.98
1,130.35
1,071.39
885.58
524.06
511.53

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Cash From Operating Activity
261.18
237.21
60.39
189.36
57.34
69.91
11.27
38.68
44.83
13.17
PBT
401.44
215.75
82.16
105.33
52.92
20.34
13.93
67.19
42.00
24.72
Adjustment
62.08
77.93
66.30
40.08
58.28
39.11
40.43
43.96
33.73
36.34
Changes in Working Capital
-90.73
-12.83
-67.58
49.22
-49.17
15.47
-40.02
-55.94
-19.17
-38.76
Cash after chg. in Working capital
372.78
280.84
80.88
194.63
62.03
74.91
14.35
55.20
56.56
22.30
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-111.60
-43.63
-20.49
-5.27
-4.68
-5.01
-3.08
-16.52
-11.73
-9.13
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-149.69
-61.50
-95.52
-84.42
-48.68
-77.23
-116.29
-42.11
-19.86
-14.13
Net Fixed Assets
-127.92
-60.11
-90.00
-105.64
-58.17
-70.35
-135.20
-142.08
-27.14
-12.02
Net Investments
-0.76
3.36
21.92
11.87
0.04
0.00
-0.01
-30.31
0.12
-0.03
Others
-21.01
-4.75
-27.44
9.35
9.45
-6.88
18.92
130.28
7.16
-2.08
Cash from Financing Activity
-69.28
-135.80
37.72
-113.66
-5.48
11.98
104.85
-0.09
-23.62
1.15
Net Cash Inflow / Outflow
42.21
39.92
2.59
-8.72
3.18
4.66
-0.17
-3.51
1.35
0.19
Opening Cash & Equivalents
45.42
5.09
2.44
11.20
7.94
3.29
3.44
6.97
0.81
0.62
Closing Cash & Equivalent
87.58
45.42
5.09
2.44
11.20
7.94
3.29
3.44
2.16
0.81

Financial Ratios

Consolidated /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Book Value (Rs.)
999.07
774.12
654.40
612.28
552.65
544.35
277.21
263.23
209.07
180.72
ROA
17.59%
11.04%
4.71%
6.31%
1.37%
1.49%
1.23%
6.65%
5.23%
3.20%
ROE
26.38%
17.84%
7.85%
10.79%
2.30%
3.48%
5.02%
22.34%
15.64%
11.24%
ROCE
33.51%
20.94%
9.44%
12.81%
7.85%
3.99%
4.07%
15.98%
18.57%
15.75%
Fixed Asset Turnover
1.54
1.28
1.09
1.22
1.18
1.26
1.13
1.57
1.86
1.82
Receivable days
86.10
91.33
86.74
79.40
84.68
97.96
129.34
93.22
87.45
94.81
Inventory Days
73.73
83.41
98.40
91.00
98.63
100.64
106.98
81.29
84.66
79.24
Payable days
114.75
110.05
116.52
111.44
65.43
75.72
82.06
67.03
85.01
92.70
Cash Conversion Cycle
45.08
64.68
68.63
58.96
117.88
122.89
154.27
107.48
87.10
81.35
Total Debt/Equity
0.06
0.12
0.28
0.22
0.37
0.33
1.30
0.82
0.98
1.17
Interest Cover
29.68
17.51
7.09
6.89
3.45
2.30
1.74
4.19
2.72
1.90

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.